BG27227A3 - METHOD FOR OBTAINING 11-DOSEXY-15-SUBSTITUTED OMEGA-PENTANORPROSTAGLANDINS - Google Patents

METHOD FOR OBTAINING 11-DOSEXY-15-SUBSTITUTED OMEGA-PENTANORPROSTAGLANDINS

Info

Publication number: BG27227A3
Authority: BG; Bulgaria
Prior art keywords: dosexy; pentanorprostaglandins; obtaining; substituted omega; omega
Prior art date: 1974-12-11

Application number

BG031757A

Other languages

Bulgarian (bg)

Inventor

Michael Johnson

Thomas Schaaf

Hans-Jurgen Hess

James EGGLER

Jasjit Bindra

Original Assignee

Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-12-11

Filing date

1975-12-11

Publication date

1979-09-14

1975-12-11 Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware

1979-09-14 Publication of BG27227A3 publication Critical patent/BG27227A3/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Crystallography & Structural Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BG031757A 1974-12-11 1975-12-11 METHOD FOR OBTAINING 11-DOSEXY-15-SUBSTITUTED OMEGA-PENTANORPROSTAGLANDINS BG27227A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53167674A	1974-12-11	1974-12-11

Publications (1)

Publication Number	Publication Date
BG27227A3 true BG27227A3 (en)	1979-09-14

Family

ID=24118594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG031757A BG27227A3 (en)	1974-12-11	1975-12-11	METHOD FOR OBTAINING 11-DOSEXY-15-SUBSTITUTED OMEGA-PENTANORPROSTAGLANDINS

Country Status (22)

Country	Link
JP (3)	JPS51125257A (en)
AT (1)	AT351185B (en)
BE (1)	BE836564A (en)
BG (1)	BG27227A3 (en)
CH (1)	CH610302A5 (en)
CS (3)	CS194746B2 (en)
DD (3)	DD129649A5 (en)
DE (1)	DE2555210A1 (en)
DK (1)	DK559975A (en)
ES (1)	ES443421A1 (en)
FI (1)	FI753475A (en)
FR (1)	FR2293923A1 (en)
GB (3)	GB1508169A (en)
GR (1)	GR60310B (en)
IE (1)	IE43815B1 (en)
IL (2)	IL48617A0 (en)
LU (1)	LU73997A1 (en)
NL (1)	NL166015C (en)
NO (1)	NO754195L (en)
NZ (1)	NZ179502A (en)
SE (1)	SE7513602L (en)
ZA (1)	ZA747723B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5486540A (en) *	1993-10-28	1996-01-23	Allergan, Inc.	Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
WO2000015608A1 (en) *	1998-09-14	2000-03-23	Ono Pharmaceutical Co., Ltd.	φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
US9284274B2 (en)	2005-12-07	2016-03-15	Ramot At Tel-Aviv University Ltd.	Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
AU2006322844A1 (en) *	2005-12-07	2007-06-14	Ramot At Tel Aviv University Ltd.	Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US9284252B2 (en)	2009-06-09	2016-03-15	Sepal Pharma Ltd.	Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
AU2013292356B2 (en)	2012-07-19	2018-02-01	Cayman Chemical Company, Inc.	Difluorolactam compositions for EP4-mediated osteo related diseases and conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES416865A1 (en) *	1972-07-13	1976-03-01	Pfizer	15-substituted-omega-pentanorprostaglandins

1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/en unknown
1975
- 1975-11-11 GR GR49337A patent/GR60310B/en unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/en unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/en unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/en active Pending
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 DK DK559975A patent/DK559975A/en not_active Application Discontinuation
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-10 NZ NZ179502A patent/NZ179502A/en unknown
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-11 DD DD7500197926A patent/DD129649A5/en unknown
- 1975-12-11 CS CS771242A patent/CS194746B2/en unknown
- 1975-12-11 BE BE1007076A patent/BE836564A/en not_active IP Right Cessation
- 1975-12-11 CS CS771241A patent/CS194745B2/en unknown
- 1975-12-11 NL NL7514446.A patent/NL166015C/en not_active IP Right Cessation
- 1975-12-11 DD DD7500197925A patent/DD129783A5/en unknown
- 1975-12-11 JP JP50148319A patent/JPS51125257A/en active Pending
- 1975-12-11 ES ES443421A patent/ES443421A1/en not_active Expired
- 1975-12-11 FR FR7537944A patent/FR2293923A1/en active Granted
- 1975-12-11 AT AT941675A patent/AT351185B/en not_active IP Right Cessation
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 BG BG031757A patent/BG27227A3/en unknown
- 1975-12-11 CH CH1610875A patent/CH610302A5/en not_active IP Right Cessation
- 1975-12-11 CS CS758428A patent/CS194733B2/en unknown
1977
- 1977-03-11 JP JP2687577A patent/JPS52102258A/en active Pending
- 1977-03-11 JP JP2687477A patent/JPS52102270A/en active Pending
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/en unknown

Also Published As

Publication number	Publication date
CS194746B2 (en)	1979-12-31
DD129649A5 (en)	1978-02-01
ES443421A1 (en)	1977-04-16
NL7514446A (en)	1976-06-15
JPS52102258A (en)	1977-08-27
SE7513602L (en)	1976-06-14
FI753475A (en)	1976-06-12
NL166015B (en)	1981-01-15
FR2293923A1 (en)	1976-07-09
ZA747723B (en)	1976-11-24
NL166015C (en)	1981-06-15
NO754195L (en)	1976-06-14
DD125828A5 (en)	1977-05-18
IE43815L (en)	1976-06-11
IL56863A0 (en)	1979-05-31
BE836564A (en)	1976-06-11
GB1508169A (en)	1978-04-19
AU8736275A (en)	1977-10-13
JPS52102270A (en)	1977-08-27
CS194733B2 (en)	1979-12-31
ATA941675A (en)	1978-12-15
IE43815B1 (en)	1981-06-03
GB1508170A (en)	1978-04-19
IL48617A0 (en)	1976-02-29
CH610302A5 (en)	1979-04-12
GR60310B (en)	1978-05-08
GB1508168A (en)	1978-04-19
FR2293923B1 (en)	1979-02-23
NZ179502A (en)	1979-01-11
JPS51125257A (en)	1976-11-01
DK559975A (en)	1976-06-12
DD129783A5 (en)	1978-02-08
CS194745B2 (en)	1979-12-31
DE2555210A1 (en)	1976-06-16
LU73997A1 (en)	1976-11-11
AT351185B (en)	1979-07-10

Publication	Publication Date	Title
BG26398A3 (en)	1979-03-15	METHOD FOR OBTAINING N-PHOSPHONOMETHYLGLYCINE
BG26536A4 (en)	1979-04-12	METHOD FOR OBTAINING SUBSTITUTED PURINES
BG23216A3 (en)	1977-07-12	METHOD FOR OBTAINING BENZIMIDAZOLES
BG26192A3 (en)	1979-02-15	METHOD FOR THE PREPARATION OF 3-ARYLOXY-3-PHENYLPROPYLAMINE
BG26516A3 (en)	1979-04-12	METHOD FOR OBTAINING N-PHOSPHONOMETHYL-GLYCINE
SE7512075L (en)	1976-05-03	CONTINUOUS CARBONING METHOD
BG26201A3 (en)	1979-02-15	METHOD FOR OBTAINING 7-BETA-AMINO-3-CEPHEM-3-OL-4-CARBONIC ACIDS
SE410725B (en)	1979-10-29	ARKSORTING APPARATUS
BG27091A3 (en)	1979-08-15	METHOD FOR OBTAINING CEPHAM DERIVATIVES
BG23541A3 (en)	1977-09-15	METHOD FOR OBTAINING PYRIDOBENZODIAZEPINONES
BG26400A3 (en)	1979-03-15	METHOD FOR OBTAINING DIAMINOCYCLITOL DERIVATIVES
BG24539A3 (en)	1978-03-10	METHOD FOR THE PREPARATION OF 1-ETHYL- FOR - SUBSTITUTED - PHENYL - DECAHYDROISOQUINOLINES
BG27230A3 (en)	1979-09-14	METHOD FOR OBTAINING SUBSTITUTED INDOLENES
SE409641B (en)	1979-09-03	LOPARE FOR BLIXTLAS
BG27227A3 (en)	1979-09-14	METHOD FOR OBTAINING 11-DOSEXY-15-SUBSTITUTED OMEGA-PENTANORPROSTAGLANDINS
BG26535A3 (en)	1979-04-12	METHOD FOR OBTAINING INDOLQUINOLYSINES
BG27076A3 (en)	1979-08-15	METHOD FOR OBTAINING ACETYLOCTENNITRILE DERIVATIVE
BG27089A3 (en)	1979-08-15	METHOD FOR OBTAINING INDOQUINOLISIDINE DERIVATIVES
BG26393A3 (en)	1979-03-15	METHOD FOR OBTAINING DEACETOXYCEPHALOSPORINS
SE381512B (en)	1975-12-08	CALORIMETRIC METHOD
BG26381A3 (en)	1979-03-15	METHOD FOR OBTAINING SUBSTITUTED PHENYLPIPERAZINES
BG26534A4 (en)	1979-04-12	METHOD FOR OBTAINING 2-METHYL-2-CYANOMETHYL-5-ISOPROPYLTETRAHYDROFURAN
BG27083A3 (en)	1979-08-15	METHOD FOR PREPARING SUBSTITUTED 1-SULFONYLBENZIMIDAZOLES
SU538660A3 (en)	1976-12-05	The method of obtaining-tert.-butylaminomethyl4-hydroxy-α-xylene-β-diol
BG25998A3 (en)	1979-01-12	METHOD FOR OBTAINING 3-CEPHEM-3-SULFONATE ESTERS COMPOUNDS